Novavax, Inc.
CH ˙ SWX ˙ US6700024010
SecurityCH:NVAX / Novavax, Inc.
InstitutionMonaco Asset Management SAM
Latest Disclosed Ownership697,600 shares
Latest Disclosed Value $ 5,678,464
Monaco Asset Management SAM reports 33.24% decrease in ownership of NVAX / Novavax, Inc.

On May 11, 2026 - Monaco Asset Management SAM filed a 13F-HR form disclosing ownership of 697,600 shares of Novavax, Inc. (CH:NVAX) valued at $5,678,464 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 1,045,000 shares of Novavax, Inc.. This represents a change in shares of -33.24% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F NOVAVAX COM NEW 670002401 697,600 -347,400 -33.24 5,678 -19.14 1.0470
2026-02-10 2025-12-31 13F NOVAVAX COM NEW 670002401 1,045,000 645,000 161.25 7,022 102.48 1.2160
2025-11-10 2025-09-30 13F NOVAVAX COM NEW 670002401 400,000 170,000 73.91 3,468 139.34 0.2105
2025-08-07 2025-06-30 13F NOVAVAX COM NEW 670002401 230,000 -60,000 -20.69 1,449 -22.01 0.2540
2025-05-08 2025-03-31 13F NOVAVAX COM NEW 670002401 290,000 5,000 1.75 1,859 -18.90 0.3795
2025-02-10 2024-12-31 13F NOVAVAX COM NEW 670002401 285,000 222,500 356.00 2,291 190.37 0.3321
2024-11-07 2024-09-30 13F NOVAVAX COM NEW 670002401 62,500 -22,500 -26.47 789 -26.67 0.1143
2024-08-07 2024-06-30 13F NOVAVAX COM NEW 670002401 85,000 -103,900 -55.00 1,076 19.29 0.1715
2024-05-09 2024-03-31 13F NOVAVAX COM NEW 670002401 188,900 121,751 181.31 903 180.12 0.2702
2024-02-07 2023-12-31 13F NOVAVAX COM NEW 670002401 67,149 37,149 123.83 322 48.39 0.0949
2023-11-07 2023-09-30 13F NOVAVAX COM NEW 670002401 30,000 -34,371 -53.40 217 -54.60 0.0644
2023-08-08 2023-06-30 13F NOVAVAX COM NEW 670002401 64,371 64,371 478 0.1335
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.